Clinical Laboratory Services Market Overview By Type (Biochemistry, Endocrinology, Microbiology, Hematology, Histopathology, Cytology, Genetic Testing and Others), By Application (Independent, Laboratory, Reference Laboratory and Hospital Laboratory) and Region (Americas, Europe, Asia Pacific, and The Middle East & Africa) – Global Forecast till 2023, by Market Research Future
Market Analysis
The clinical laboratory services market is anticipated to touch USD 274,400 million at a favorable CAGR between 2018-2023, states the latest Market Research Future (MRFR) report. Clinical laboratory services are healthcare facilities that offer an array of laboratory procedures that help physicians to perform the diagnosis, management, and treatment of patients. Such clinical laboratories are manned by clinical laboratory scientists/medical technologists that are highly trained in performing various tests.
Leading Market Players
Notable players profiled in the clinical laboratory services market size report include Adicon Clinical Laboratory (China), Sonic Healthcare (UK), Unilabs (Switzerland), Eurofins Scientific (Luxembourg), Synlab International (Germany), Amedes Holdings (Germany), Cerba Healthcare Quest Diagnostics Incorporated (France), Lifelabs Medicals Laboratories (Canada), ACM Medical Laboratory (US), Clinical Reference Laboratory (US), Bio-Reference Laboratories (US), Mayo Medical Laboratories (US), Spectra Laboratories Inc (US), and Laboratory Corporation of America Holdings (US).
Market Drivers
Various factors are propelling the clinical laboratory services market growth. Some of these factors, according to the Market Research Future report, include the growing cases of kidney failure, liver dysfunction, diabetes, and cancer, developments in clinical diagnostic techniques, grants and funding for developing innovating laboratory testing procedures, growing private-public investments, and growing demand for accurate and early disease diagnosis. Additional factors pushing growth of the clinical laboratory services market include the increasing adoption of technologically advanced products namely biochips, companion diagnostics, and microarrays, increasing number of people having neurological and cardiovascular diseases, the growing awareness about early diagnosis of conditions especially in oncology, endocrinology, and gynecology, and benefits that it offers such as minimal stay in the hospital and reduced frequency of visit to the doctor.
Market Segmentation
The MRFR report provides an all-inclusive segmental analysis of the clinical laboratory services market on the basis of application and type.
Based on type, the clinical laboratory services market is segmented into genetic testing, cytology, histopathology, microbiology, hematology, endocrinology, biochemistry, and others. Of these, the hematology segment will lead the market during the forecast period. Different factors pushing the growth of this segment include the high prevalence of blood cancer, growing need for chemistry testing, and advancements of technology in genetic testing.
Based on the application, the clinical laboratory services market is segmented into the hospital laboratory, reference laboratory, and independent laboratory. Of these, the hospital laboratory will dominate the market during the forecast period. Different factors pushing the growth of the segment include the increasing incidence of infectious diseases, wide-ranging services offered by hospital laboratories, and the availability of independent laboratories.
Market Research Future (MRFR) publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit- https://www.marketresearchfuture.com/reports/clinical-laboratory-services-market-7145
Industry News
October 2019: Cayuga Health System has begun new diabetes and endocrinology program. This program will be conducted through a multidisciplinary team of health educators, nurses, and physicians who will treat endocrine disorders, which cause different effects on the body.
Related Healthcare News
Immunoassay Analyzers Market
High Throughput Screening Market
About Market Research Future:
Global Odontogenic Tumor Market, by Tumor Type (Malignant Odontogenic Tumor and Others), by Diagnosis (Computerized Tomography Scan and Others), by Treatment (Surgery and Others), by End-Users (Dental Clinics, Hospitals, and Others)– Forecast Till 2027Market HighlightsThe odontogenic tumor is the abnormal growth of cells in and around the jaws and teeth.
In usual cases, odontogenic tumors are malignant means they are likely to spread in jaws and teeth.
This tumor can be diagnosed using different techniques such as computerized tomography scan (also called a CT or CAT scan), magnetic resonance imaging (MRI), and biopsy.
The increasing incidence of the odontogenic tumor and other dental-related diseases, rising geriatric population, and increasing incidence of children suffering from an odontogenic tumor and dental clinics are anticipated to drive the growth of the market during the forecast period.
However, unfavorable reimbursement scenario and lack of awareness among the people regarding odontogenic tumor may hamper the growth of the market during the assessment period.
The key players in the market are engaged in new launches and strategic collaborations to hold their market position.Regional AnalysisThe market in the Americas is expected to dominate the global odontogenic market during the forecast period owing to the increasing prevalence of odontogenic tumor diseases along with the growing geriatric population and well-established healthcare sector in the region.
According to the new market research report “Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User -Global Forecast” published by MarketsandMarkets™Revenue Growth Opportunities and Growth Drivers?The Global Kidney/Renal Function Test Market is expected to reach USD 790.1 Million, growing at a CAGR of 6.1% during the forecast period.Growth Boosting Factors:# Rising Prevalence of Kidney Disease# Rapid Growth in Geriatric Population#Growing Prevalence of Diabetes and Hypertension# Rise in Consumption of AlcoholAsk for Free Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=40239083Leading Key Players in the Worldwide Industry:The prominent players in the global kidney/renal function test market are Abbott (US), Siemens (Germany), Sysmex (Japan), Beckman Coulter (US), Roche (Switzerland), ACON Laboratories, Inc. (US), URIT Medical (China), Nova Biomedical (US), ARKRAY (Japan), OPTI Medical (US), 77 Elektronika (Hungary), and Randox Laboratories (UK).Geographical Regions Mapped in Report:North America is estimated to account for the largest share of the Kidney Function Test Market, followed by Europe.
This large share can be attributed to factors such as the increasing incidence of chronic diseases, rising prevalence of hypertension, growing incidence of diabetes in the US, and increasing initiatives by the Canadian government for the awareness and treatment of kidney diseases.
However, the Asia Pacific region is expected to register the highest CAGR during the forecast period.Ask for Free PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40239083Market Segmentation in Detailed:Based on product, the Kidney Function Test Market is categorized into dipsticks, reagents, and disposables.
The dipsticks segment is expected to account for the largest share of the market in 2017 and is also estimated to grow at the highest CAGR during the forecast period.
Factors contributing to the large share of the market include the cost-effectiveness of dipstick testing, which also accounts for its widespread application across the globe.Based on type, the Renal Function Test Market is segmented into urine tests and blood tests.
Urine tests are further categorized into urine protein, creatinine clearance, and microalbumin tests.
The global infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%.
The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022.
Growth in this market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnosticsDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589Global Market Segmentation:The market is broadly segmented into assays, kits, & reagents; instruments; and services & software based on product & service.
The assays, kits, & reagents segment accounted for the largest share of the global market and is expected to register the highest CAGR during the forecast period.
The increasing number of infectious disease diagnostic tests carried out; easy accessibility to a wide range of reagents; and the growing need for reliable, specific, and faster detection of infectious diseases in the early stages are the key factors driving the IDD assays, kits, & reagents market.Based on the disease type, the market is segmented into hepatitis, HIV, HAIs, CT/NG, HPV, TB, Influenza, and other diseases.
The hepatitis diagnostics segment accounted for the largest share of the global market in 2017.
Factors contributing to the growth of this market include the rising incidence and prevalence of chronic and infectious diseases, growing funding for cancer research, growing cell-based research, and development of apoptosis-modulating drugs.The global apoptosis assays market is projected to reach USD 5.9 billion by 2023 from USD 3.6 billion in 2018, at a CAGR of 10.5%.Based on detection technology, the cell imaging and microscopy is expected to grow at the fastest growth rate during the forecast period.
The cell imaging and microscopy segment is expected to witness the highest CAGR due to its increasing adoption of cell imaging and microscopy in diagnostic laboratories, drug discovery applications, and basic research.On the basis of product, the assay kits segment is expected to account for the largest share of the market in 2018.
The large share can be attributed to the repeated consumption of assays in various apoptosis procedures.
On the other hand, among all the detection technology, the flow cytometry is most widely used for apoptosis process.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=9069428Region Covered in Apoptosis Assay MarketThe apoptosis assays market in APAC is expected to grow at the highest CAGR during the forecast period.
The highest CAGR is due to the increasing prevalence of chronic and infectious diseases in this region, large patient population, increasing healthcare spending, and growing interest of key players in APAC countries.
Also, owing to the high growth opportunities in the APAC region, many manufacturers are expanding their global manufacturing bases to this region.With their low-cost manufacturing advantage, China and India are regarded as the most profitable manufacturing and R locations by manufacturers.
Microalbumin Test Market Research Report: By Product (Analyzer, Reagent Kit, Control Kit, Micro-Cuvettes, Test Strips), Indication (Kidney Disease, Diabetes, High Blood Pressure), End User (Hospitals, Diagnostics Laboratories) – Global Forecast till 2027Market AnalysisThe global microalbumin test market is projected to boom at an astral 5.1% CAGR over the assessment period (2017-2023).
Microalbumin test is a kind of urine test which is used for diagnosing kidney diseases.
Microalbumin test, creatinine clearance tests and urine protein tests are widely utilized urine tests in diagnostic centers and hospitals.
Some of these factors as per the Market Research Future (MRFR) report include rising prevalence of renal dysfunction, diabetes and other forms of kidney problems, increasing R activities, advancements in technology in the medical device domain, rising geriatric population and demand for diagnostic and treatment for chronic diseases.
Apart from this, the other factors that are driving the growth of the microalbumin test market in this region include the existence of key market players and rising need for diagnostic devices that are technologically advanced.
The microalbumin test market in the Middle East is growing owing to sedentary lifestyle and lack of physical exercise and in Africa the factors that are driving the market growth include demand for diagnosis and treatment procedures for chronic diseases.Key PlayersLeading players profiled in the microalbumin test market include Randox Laboratories (U.K).
Market Highlights:Global Blood Collection Market Research Report: by Type of blood collection (capillary, venous, vacuum), by product (blood collection devices, blood collection tubes, needles and syringes, lancets), by method (automated, manual), end user – Forecast Till 2023The Global Blood Collection Market is expected to grow at a CAGR of 6.1% during the forecast period.
Increasing prevalence of chronic conditions, advancements in healthcare facilities, and favorable funding policies are expected to drive the market growth over the forecast period.
According to the World Health Organization (WHO), there are over 35 Million healthcare workers and these workers face an increased risk of infection from blood-borne pathogens simply because of their exposure to blood and other body fluids.
However, blood contamination and injury caused by blood collection devices can restrain the market growth over the assessment period.Key Players:Some of the prominent players in the global blood collection market-BD, Medtronic, Terumo, Haemonetics, Fresenius, Nipro Medical, Kawasumi Laboratories, F.L.
Medical, Greiner Holding, Grifols, B. Braun Melsungen AG, Thermo Fisher Scientific Inc., HTL-STREFA S.A., Sarstedt AG & Co and others.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7013 Segmentation:The Global Blood Collection Market has been segmented into type of blood collection, product, method, and end user.The market, on the basis of type of blood collection, has been segmented into capillary blood collection, venous blood collection, and vacuum blood collection.The market, by product, has been segmented into blood collection devices, blood collection tubes and collector, needles and syringes, warming devices, blood bags, lancets, and others.
The blood collection tubes and collector segment is further classified as serum collection tubes, and plasma or whole blood collection tubes.
